Kite and Gadeta collaborate to target solid tumors
Kite has collaborated with Gadeta to work on the research and development of immunotherapies involving gamma delta TCR cell receptors.
Kite has collaborated with Gadeta to work on the research and development of immunotherapies involving gamma delta TCR cell receptors.
The US FDA has issued draft guidance documents to support the preparation of investigational new drug applications for human gene therapies.
Major pharmaceutical firms Novartis, Roche, and Pfizer have reacted to the US FDA’s Biosimilar Action Plan, which aims to “strike a balance” between innovation and market competition.